Login
$BOBS
$16.01 -$0.27 (1.66%) Close

$BOBS SEC Filings

Filed On Filing
07 Aug 2026 8-K: Regulation FD Disclosure
06 Aug 2026 SCHEDULE 13G
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition
20 May 2026 Form 4: Moeller Stephen, See Remarks

Received 30,000 shares by exercise or conversion ($168K)

15 May 2026 SCHEDULE 13G
12 May 2026 Form 4: Barton William G, Director

Bought 22,150 shares ($300K) · Bought 200 shares ($2.43K)

07 May 2026 10-Q
07 May 2026 8-K: Results of Operations and Financial Condition
30 Apr 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
27 Mar 2026 Form 4: Glaser Carol, See Remarks

Received 10,000 shares by exercise or conversion ($20.4K) · Received 25,000 shares by exercise or conversion ($51K)

18 Mar 2026 10-K
17 Mar 2026 8-K: Results of Operations and Financial Condition
13 Feb 2026 Form 4: Kilgallon John Thomas, Director

Sold 2,917,500 shares ($46.5M)

13 Feb 2026 Form 4: Bain Capital Investors Llc, 10% owner and 4 others

Sold 2,917,500 shares ($46.5M)

13 Feb 2026 Form 4: Barton William G, Director

Granted 138,471 Stock Options (Right to Buy)

13 Feb 2026 Form 4: Kang Soyoung, Director

Granted 4,062 Stock Options (Right to Buy)

13 Feb 2026 Form 4: Aamir Mir M, Director

Granted 4,062 Stock Options (Right to Buy)

13 Feb 2026 Form 4: Nesle Stephen, See Remarks

Granted 11,015 Stock Options (Right to Buy)

13 Feb 2026 Form 4: Davies Patricia, See Remarks

Granted 10,595 Stock Options (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support